Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Qiagen launches therascreen IDH1/2 test for gliomas and collaborates with Mayo Clinic

Jan. 8, 2014

RadioMedix receives orphan drug designation for GalioMedix

Jan. 7, 2014

FDA clearance for AmpliVue Group B Strep assay

Dec. 31, 2013

Cellmid provides data from CK3000 study program

Dec. 20, 2013

Merck & Co. presents novel PET imaging agents for AD

Dec. 20, 2013

PIVKA-II test kit for HCC launched in Japan

Dec. 18, 2013

Novel radioligand described for imaging Abeta in AD

Dec. 18, 2013

Navidea Biopharmaceuticals submits supplemental NDA to FDA for Lymphoseek

Dec. 18, 2013

Endocyte begins phase I study of EC-1456 in advanced solid tumors

Dec. 16, 2013

C4 Imaging receives FDA 510(k) clearance for Sirius

Dec. 13, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....